SCHEMBL10415375

SCHEMBL10415375

Nc1cccc(CN2CCC(CN3CCc4ccccc4C3)CC2)c1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.58
F10 P00742 2/20 0.52
HTR1A P08908 1/20 0.46
SIGMAR1 Q99720 1/20 0.46
PRMT5 O14744 2/20 0.45
WDR77 Q9BQA1 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.44
THRB P10828 1/20 0.44
CHRM2 P08172 1/20 0.43
CHRM3 P20309 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
GLA P06280 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43
ATM Q13315 1/20 0.43
PARP1 P09874 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL10415652 0.91 ACHE (0.52) ACHEF10PRMT5WDR77L3MBTL1
Fumaric Acid SCHEMBL10415651 0.91 ACHE (0.52) ACHEF10PRMT5WDR77L3MBTL1
SCHEMBL7540594 0.86 ACHE (0.76) ACHEHTR1ASIGMAR1PRMT5WDR77
SCHEMBL8304595 0.86 L3MBTL1 (0.55) ACHESIGMAR1L3MBTL1KDM4EALDH1A1
SCHEMBL10483079 0.86 MAPT (0.62) ACHEHTR1ASIGMAR1PRMT5WDR77
Hydrochloric Acid SCHEMBL10415385 0.85 ACHE (0.74) ACHEHTR1ASIGMAR1PRMT5WDR77
Hydrochloric Acid SCHEMBL6968014 0.85 L3MBTL1 (0.54) ACHESIGMAR1L3MBTL1KDM4EALDH1A1
SCHEMBL12533238 0.83 MEN1 (0.51) F10KDM4EGAA
SCHEMBL10416145 0.83 ACHE (0.55) ACHEHTR1ASIGMAR1PRMT5WDR77
SCHEMBL10414142 0.82 MEN1 (0.67) ACHESIGMAR1KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4945096-A Treatment of a depressive state with 2-[(4-piperidyl)methyl]-1,2,3,4-tetrahydroisoquinoline derivates SYNTHELABO (FR) 1990-07-31 US disclosed
US-4885302-A 2-((4-Piperidyl)methyl)-1,2,3,4-tetrahydroisoquinoline derivatives, their preparation and their application in therapy SYNTHELABO, 58, RUE DE LA GLACIERE - 75013 PARIS 1989-12-05 US disclosed